3 Reasons SpaceX Stock Could Crash in Q4 -- and 1 Reason It Won't

SpaceX shares are down more than 7% year to date, and the article flags a potentially material insider-share overhang when its 180-day IPO lockup expires in early December. Q2 revenue rose 92% year over year to $7.8B, but the company reported a $541M net loss, $28.5B in first-half capex, and negative 2025 free cash flow of $13.8B; following those results, shares opened 13.6% lower on Aug. 5. With a trailing price-to-sales ratio of 94.8, disappointing Q3 results, higher capex expectations, or operational setbacks could drive valuation compression, though Starlink, launch leadership, and vertical integration provide long-term support.

Analysis

SPCX is entering the unfavorable portion of the post-IPO lifecycle: a capital-intensive business whose public float will expand before investors have a credible framework for normalized free-cash-flow conversion. The relevant risk is not simply incremental selling; it is price discovery as early holders with markedly lower cost bases monetize into a relatively young institutional ownership base. At the stated sales multiple, even a modest de-rating toward premium infrastructure/software comparables would dominate any near-term revenue beat, making Q3 guidance and capex commentary more important than reported revenue growth.

The second-order read-through is negative for other long-duration, capex-heavy "physical AI" stories, particularly TSLA if investors begin questioning whether Musk-affiliated projects can finance ambitious compute and infrastructure programs without sustained external capital. Conversely, established defense primes and profitable satellite/communications operators could attract relative flows if investors rotate from duration-sensitive space exposure toward contracted cash flows; RTX, LMT, NOC, IRDM and VSAT are the cleaner watchlist beneficiaries. The claimed compute-hosting opportunity should receive little valuation credit until management discloses customer commitments, power economics, utilization, and whether those contracts are backed by investment-grade counterparties.

The near-term setup is asymmetric to the downside through earnings and the broader December supply event, but the consensus may be too focused on a mechanical unlock cliff. A large portion of insider supply may be pre-arranged, absorbed by strategic buyers, or offset by restricted liquidity, while a credible launch milestone or improved capex trajectory could force a sharp short-covering rally. The bear thesis is falsified by Q3 evidence that incremental revenue is scaling faster than capex, alongside stable or improving free-cash-flow guidance and orderly trading through the initial unlocked-share window; absent those data, this is principally a valuation-and-financing-risk trade rather than a challenge to the long-run strategic moat.

Key Decisions for Investors

• Initiate a 1-3 month tactical short in SPCX only after confirming borrow availability and liquid options/open interest; size modestly ahead of earnings, with a larger add on a guidance-led break below the post-earnings low. Target 20-30% downside into the December supply event; cover if management shows materially lower forward capex or positive free-cash-flow inflection.
• Prefer a relative-value expression: long LMT or RTX versus short SPCX in dollar-neutral size through December. The trade isolates a rotation from unpriced duration to defense cash flows; reassess if defense-budget headlines deteriorate or SPCX demonstrates contracted, high-margin recurring revenue sufficient to defend its premium multiple.
• Avoid treating the early unlock-day decline as proof of permanent supply pressure. Monitor disclosed insider-sale plans, daily traded value, institutional allocations and short interest during the first unlocked tranche; if absorption is orderly and volume expands without new lows, do not add to shorts before earnings.
• For TSLA, maintain a watch item rather than a directional trade: reduce relative exposure only if SPCX financing needs or AI-infrastructure spending become linked to broader Musk-ecosystem capital allocation. The actionable trigger is a material revision to Tesla capex, related-party disclosures, or a widening TSLA-versus-Mag-7 valuation discount.